Work

Erratum to “INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease” [J Prev Alzheimers Dis 2025;12(1): 100005.]

Year: 2025

Type: erratum

Source: The Journal of Prevention of Alzheimer s Disease

DOI: 10.1016/j.tjpad.2025.100213

Authors: Eric Siemers, Todd Feaster, Gopalan Sethuraman, Karen Sundell, Vladimir Skljarevski, Erika N. Cline, Hao Zhang, Jasna Jerecic, Lawrence S. Honig, Stephen Salloway, Reisa Sperling, Mirjam N. Trame, Michael G. Dodds, Kimball Johnson

Institutions: Acumen Pharmaceuticals (United States), Columbia University Irving Medical Center, Brown University, Butler Hospital, Harvard University, iResearch Atlanta

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,060

OpenAlex ID: W4410888092

Cites:

Cited by:

Related to: 10